Distribuzione geografica
Continente #
EU - Europa 16337
Totale 16337
Nazione #
IT - Italia 16337
Totale 16337
Città #
Genova 14726
Rapallo 1231
Genoa 380
Totale 16337
Nome #
Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin. 164
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 162
Update on cardiotoxicity of anti-cancer treatments 155
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 153
Autophagy in blood cancers: biological role and therapeutic implications. 151
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 149
1221 POSTER Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 147
The vulnerable coronary plaque: update on imaging technologies. 146
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 145
Nicotinic acid phosphoribosyltransferase regulates cancer cell metabolism, susceptibility to NAMPT inhibitors and DNA repair. 144
SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells 140
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells vulnerability to DNA-damaging agents 138
Simulation-Based Education for Physicians to Increase Oral Anticoagulants in Hospitalized Elderly Patients with Atrial Fibrillation 137
Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. 135
Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics 135
Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation 134
Anticancer vaccination strategies. 133
Pathophysiological role of neutrophils in acute myocardial infarction. 132
Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas. 130
APO866 activity in hematologic malignancies: a preclinical in vitro study. 128
Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives. 128
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 128
Ras-induced resistance to lapatinib is overcome by MEK inhibition 127
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 127
Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies. 127
An emerging role of glucagon-like Peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes. 126
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 125
Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors As Therapeutics: Rationales, Controversies, Clinical Experience. 125
Fasting and cancer: molecular mechanisms and clinical application 125
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial 124
null 123
Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics. 122
null 122
null 121
Discovery of novel and selective SIRT6 inhibitors. 118
Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response 118
Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice 118
Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model 117
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 117
Synthesis of Pyrrolidine 3,4-Diol Derivatives with Anticancer Activity on Pancreatic Tumor Cells 116
Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases. 115
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 114
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 114
Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters. 114
Sirt6 regulates dendritic cell differentiation, maturation, and function 113
SIRT6 inhibitors with salicylate-like structure show immunosuppressive and chemosensitizing effects 113
Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells 111
New insights into biology of chronic myeloid leukemia: implications in therapy. 109
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 109
Autoimmunity as the consequence of a spontaneous mutation in Rasgrp1 108
null 108
CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells. 106
Delirium, Frailty, and Fast-Track Surgery in Oncogeriatrics: Is There a Link? 106
null 105
null 104
null 104
Evaluating treatment response of chronic myeloid leukemia: emerging science and technology. 104
Evaluation of prognostic indices in elderly hospitalized patients 104
EIF2A-dependent translational arrest protects leukemia cells from the energetic stress induced by NAMPT inhibition 104
Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes. 103
Nicotinamide Phosphoribosyltransferase As A Target In Inflammation-Related Disorders. 103
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 103
New perspectives in dendritic cell-based cancer immunotherapy. 102
Intracellular NAD⁺ depletion enhances bortezomib-induced anti-myeloma activity. 102
null 102
Carvedilol Prevents Doxorubicin-induced Free Radical release and Oxidative Damage in Cardiomyocytes. 102
Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA 102
The proteasome and its inhibitors in immune regulation and immune disorders. 101
Synthetic lethality-based therapeutics: perspectives for applications in colorectal cancer. 101
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer 100
Immunotherapy with dendritic cells for cancer 99
Transfection of dendritic cells with RNA induces CD4- and CD8-mediated T cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopes. 99
Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling. 99
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 97
The use of dendritic cells in cancer immunotherapy. 97
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 96
Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 96
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 96
Synthesis of new oxathiazinane dioxides and their in vitro cancer cell growth inhibitory activity. 96
Intracellular NAD+ depletion induces autophagic-death in Multiple Myeloma cells 96
Cellular immunotherapy with dendritic cells in cancer: current status. 95
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 95
Crosspresentation: a matter of pH. 95
The In-Hospital Length of Stay after Hip Fracture in Octogenarians: Do Delirium and Dementia Shape a New Care Process? 95
null 94
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards 94
Proteasome inhibitors: antitumor effects and beyond 94
Fasting potentiates the anticancer activity of tyrosin kinase inhibitors by strenghtening MAPK signalling inhibition. 93
Targeting NAD(+) Salvage Pathway Induces Autophagy in Multiple Myeloma Cells 92
The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level 92
Nicotinic acid: A case for a vitamin that moonlights for cancer? 92
null 92
Targeting NAD+ Salvage Pathway Induces Autophagy in Multiple Myeloma Cells via mTORC1 and Extracellular Signal-Regulated Kinase (ERK1/2) Inhibition 91
Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome. 91
Selectivity hot-spots of sirtuin catalytic cores 91
null 91
Differential modulation of SIRT6 deacetylase and deacylase activities by lysine-based small molecules 91
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 90
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis 90
The plant hormone abscisic acid increases in human plasma after hyperglycemia and stimulates glucose consumption by adipocytes and myoblasts 90
Totale 11317
Categoria #
all - tutte 26060
article - articoli 25101
book - libri 0
conference - conferenze 479
curatela - curatele 0
other - altro 0
patent - brevetti 281
selected - selezionate 0
volume - volumi 199
Totale 52120

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20181338 0000 0591 184373 15515020
2018/20191400 11563623 1877 2235 43228445406
2019/20205516 245125194468 521644 847411 505821533202
2020/20212028 105194188171 189170 95195 156245166154
2021/20222604 77200172340 117203 135541 134253122310
2022/20231614 30429040341 525114 00 0000
Totale 16761